Summary by Moomoo AI
With effect from 31 December 2023, Keystone Pharmaceuticals announced that, pursuant to Section 2.07 of the Securities Listing Rules of the Hong Kong Stock Exchange Limited, the Company's communications, including Directors' Reports, Annual Accounts, Audit Reports, Interim Reports, Meeting Notices, etc., will be published electronically. THE COMPANY NOTIFIES NON-REGISTERED SHAREHOLDERS THAT FUTURE CORPORATE COMMUNICATIONS WILL BE MADE AVAILABLE THROUGH THE COMPANY'S WEBSITE AND DISCLOSEABLE WEBSITE IN PLACE OF THE PRINTED COPY. Non-registered shareholders are required to provide a valid email address to the holding intermediary to receive communications. If shareholders wish to receive printed communications, they may submit an application via the online form or return. In addition, the Company reminds shareholders to note the Personal Data Collection Statement and provides contact information to process requests for access and correction of personal data.